SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-010492
Filing Date
2018-05-03
Accepted
2018-05-03 07:17:01
Documents
63
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20180331.htm 10-Q 1648374
2 EX-10.1 sage-ex101_215.htm EX-10.1 102147
3 EX-10.2 sage-ex102_367.htm EX-10.2 12688
4 EX-31.1 sage-ex311_8.htm EX-31.1 9350
5 EX-31.2 sage-ex312_7.htm EX-31.2 9286
6 EX-32.1 sage-ex321_6.htm EX-32.1 7573
7 GRAPHIC g2018050221134780027530.jpg GRAPHIC 23334
8 GRAPHIC g2018050221140369726811.jpg GRAPHIC 47530
9 GRAPHIC g2018050221140370826812.jpg GRAPHIC 45074
  Complete submission text file 0001564590-18-010492.txt   6129558

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT sage-20180331.xml EX-101.INS 1305749
11 XBRL TAXONOMY EXTENSION SCHEMA sage-20180331.xsd EX-101.SCH 42585
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20180331_cal.xml EX-101.CAL 39335
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20180331_def.xml EX-101.DEF 151517
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20180331_lab.xml EX-101.LAB 309531
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20180331_pre.xml EX-101.PRE 260334
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 18801786
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences